Tivozanib-话题@MedSci

#Tivozanib#

6篇内容 | 995人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2228078, encodeId=6e2422280e870, content=<a href='/topic/show?id=7c328264677' target=_blank style='color:#2F92EE;'>#肾细胞癌#</a> <a href='/topic/show?id=0a331e495db' target=_blank style='color:#2F92EE;'>#Tivozanib#</a>, objectTitle=抗癌药并非用得越多越好，从替沃扎尼布治疗肾癌说起！, objectType=article, longId=844736, objectId=4b58844e368e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240925/1727244336936_8538692.jpg, objectUrl=/article/show_article.do?id=4b58844e368e, replyNumber=0, likeNumber=86, createdTime=2024-09-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=4b58844e368e, moduleTitle=抗癌药并非用得越多越好，从替沃扎尼布治疗肾癌说起！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b58844e368e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1674577, encodeId=16cb16e457774, content=<a href='/topic/show?id=0a331e495db' target=_blank style='color:#2F92EE;'>#Tivozanib#</a>, objectTitle=Lancet Oncol：晚期肾细胞癌中tivozanib和sorafenib治疗比较, objectType=article, longId=186219, objectId=9cd3186219f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9cd3186219f9, replyNumber=0, likeNumber=105, createdTime=2020-08-29, rootId=0, userName=gostraight, userId=e8ba26977626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9cd3186219f9, moduleTitle=Lancet Oncol：晚期肾细胞癌中tivozanib和sorafenib治疗比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9cd3186219f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674578, encodeId=fff116e45780a, content=<a href='/topic/show?id=0a331e495db' target=_blank style='color:#2F92EE;'>#Tivozanib#</a>, objectTitle=复发难治肾细胞癌的治疗或迎新突破：FDA已批准Tivozanib的NDA, objectType=article, longId=195152, objectId=4ee01951523a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ee01951523a, replyNumber=0, likeNumber=111, createdTime=2021-01-11, rootId=0, userName=gostraight, userId=e8ba26977626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ee01951523a, moduleTitle=复发难治肾细胞癌的治疗或迎新突破：FDA已批准Tivozanib的NDA, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ee01951523a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674576, encodeId=e56d16e457691, content=<a href='/topic/show?id=0a331e495db' target=_blank style='color:#2F92EE;'>#Tivozanib#</a>, objectTitle=Lancet oncol：Tivozanib治疗转移性肾细胞癌！, objectType=article, longId=184622, objectId=33e318462202, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33e318462202, replyNumber=0, likeNumber=64, createdTime=2020-07-22, rootId=0, userName=gostraight, userId=e8ba26977626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33e318462202, moduleTitle=Lancet oncol：Tivozanib治疗转移性肾细胞癌！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33e318462202)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674575, encodeId=862316e45754d, content=<a href='/topic/show?id=0a331e495db' target=_blank style='color:#2F92EE;'>#Tivozanib#</a>, objectTitle=tivozanib治疗索拉非尼治疗后晚期肾细胞癌患者的疗效：III期交叉研究, objectType=article, longId=136869, objectId=073213686943, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=073213686943, replyNumber=0, likeNumber=76, createdTime=2018-06-26, rootId=0, userName=gostraight, userId=e8ba26977626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=073213686943, moduleTitle=tivozanib治疗索拉非尼治疗后晚期肾细胞癌患者的疗效：III期交叉研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=073213686943)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674574, encodeId=b26916e45741f, content=<a href='/topic/show?id=0a331e495db' target=_blank style='color:#2F92EE;'>#Tivozanib#</a>, objectTitle=CCC：Tivozanib联合mFOLFOX6方案治疗进展期胃肠道恶性肿瘤疗效满意, objectType=article, longId=44484, objectId=63814448489, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63814448489, replyNumber=0, likeNumber=85, createdTime=2015-11-19, rootId=0, userName=gostraight, userId=e8ba26977626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63814448489, moduleTitle=CCC：Tivozanib联合mFOLFOX6方案治疗进展期胃肠道恶性肿瘤疗效满意, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63814448489)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1674573, encodeId=857916e457361, content=<a href='/topic/show?id=0a331e495db' target=_blank style='color:#2F92EE;'>#Tivozanib#</a>, objectTitle=JCO：tivozanib治疗转移性肾细胞癌PFS结局优于索拉非尼, objectType=article, longId=24472, objectId=9929244e2c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9929244e2c5, replyNumber=0, likeNumber=65, createdTime=2014-01-02, rootId=0, userName=gostraight, userId=e8ba26977626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9929244e2c5, moduleTitle=JCO：tivozanib治疗转移性肾细胞癌PFS结局优于索拉非尼, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9929244e2c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Tivozanib

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#肾细胞癌# #Tivozanib#

抗癌药并非用得越多越好，从替沃扎尼布治疗肾癌说起！

2024-09-27发表于上海

gostraight (审核中...)

前往app查看评论内容

#Tivozanib#

Lancet Oncol：晚期肾细胞癌中tivozanib和sorafenib治疗比较

2020-08-29

gostraight (审核中...)

前往app查看评论内容

#Tivozanib#

复发难治肾细胞癌的治疗或迎新突破：FDA已批准Tivozanib的NDA

2021-01-11

gostraight (审核中...)

前往app查看评论内容

#Tivozanib#

Lancet oncol：Tivozanib治疗转移性肾细胞癌！

2020-07-22

gostraight (审核中...)

前往app查看评论内容

#Tivozanib#

tivozanib治疗索拉非尼治疗后晚期肾细胞癌患者的疗效：III期交叉研究

2018-06-26

gostraight (审核中...)

前往app查看评论内容

#Tivozanib#

CCC：Tivozanib联合mFOLFOX6方案治疗进展期胃肠道恶性肿瘤疗效满意

2015-11-19

gostraight (审核中...)

前往app查看评论内容

#Tivozanib#

JCO：tivozanib治疗转移性肾细胞癌PFS结局优于索拉非尼

2014-01-02

科室
- - 订阅+
  - 更多科室
工具
服务